Literature DB >> 11768697

Cell biology of laryngeal epithelial defenses in health and disease: preliminary studies.

S E Axford1, N Sharp, P E Ross, J P Pearson, P W Dettmar, M Panetti, J A Koufman.   

Abstract

Esophageal epithelium has intrinsic antireflux defenses, including carbonic anhydrases (CAs I to IV) that appear to be protective against gastric reflux. This study aimed to investigate the expression and distribution of CA isoenzymes in laryngeal epithelium. Laryngeal biopsy specimens collected from the vocal fold and interarytenoid regions were analyzed by Western blotting and immunofluorescence. Carbonic anhydrases I and II were expressed by the majority of samples analyzed. In contrast, CA III was differentially expressed in the interarytenoid samples and was not detected in any vocal fold samples. The expression of CA III was increased in esophagitis as compared to normal esophageal tissue. Carbonic anhydrase I and III isoenzymes were distributed cytoplasmically in the basal and lower prickle cell layers. The laryngeal epithelium expresses some CA isoenzymes and has the potential to protect itself against laryngopharyngeal reflux. Laryngeal tissue may be more sensitive to injury due to reflux damage than the esophageal mucosa because of different responses of CA isoenzymes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11768697     DOI: 10.1177/000348940111001203

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  17 in total

1.  The presence of pepsin in the lung and its relationship to pathologic gastro-esophageal reflux.

Authors:  R Rosen; N Johnston; K Hart; U Khatwa; S Nurko
Journal:  Neurogastroenterol Motil       Date:  2011-12-05       Impact factor: 3.598

Review 2.  The laryngeal and esophageal manifestations of Sjögren's syndrome.

Authors:  Peter C Belafsky; Gregory N Postma
Journal:  Curr Rheumatol Rep       Date:  2003-08       Impact factor: 4.592

Review 3.  Laryngopharyngeal reflux: the value of otolaryngology examination.

Authors:  Peter C Belafsky; Catherine J Rees
Journal:  Curr Gastroenterol Rep       Date:  2008-06

4.  Airway reflux, cough and respiratory disease.

Authors:  Ian D Molyneux; Alyn H Morice
Journal:  Ther Adv Chronic Dis       Date:  2011-07       Impact factor: 5.091

5.  Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma.

Authors:  Tina Samuels; Craig Hoekzema; Jon Gould; Matthew Goldblatt; Matthew Frelich; Matthew Bosler; Sang-Hyuk Lee; Nikki Johnston
Journal:  Ann Otol Rhinol Laryngol       Date:  2015-06-15       Impact factor: 1.547

6.  Role for ion transport in porcine vocal fold epithelial defense to acid challenge.

Authors:  Elizabeth Erickson-Levendoski; M Preeti Sivasankar
Journal:  Otolaryngol Head Neck Surg       Date:  2011-11-15       Impact factor: 3.497

7.  The integrity of esophagogastric junction anatomy in patients with isolated laryngopharyngeal reflux symptoms.

Authors:  Kyle A Perry; C Kristian Enestvedt; Cedric S F Lorenzo; Paul Schipper; Joshua Schindler; Cynthia D Morris; Katie Nason; James D Luketich; John G Hunter; Blair A Jobe
Journal:  J Gastrointest Surg       Date:  2008-08-02       Impact factor: 3.452

8.  New developments in extraesophageal reflux disease.

Authors:  Elif Saritas Yuksel; Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-09

Review 9.  Molecular pathways and genetic factors in the pathogenesis of laryngopharyngeal reflux.

Authors:  Alexios S Vardouniotis; Alexander D Karatzanis; Eleni Tzortzaki; Elias Athanasakis; Katerina D Samara; Georgios Chalkiadakis; Nikolaos Siafakas; George A Velegrakis
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-04-02       Impact factor: 2.503

10.  The influence of laryngopharyngeal reflux in the healing of laryngeal trauma.

Authors:  Ilias Kantas; Dimitrios G Balatsouras; Nikolaos Kamargianis; Michael Katotomichelakis; Maria Riga; Vasilis Danielidis
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-07-05       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.